“Non-invasive” sampling allows the necessary repeatability in sport or other contexts, given the lack of physical distance.
VOGO connected device in the field allows a decentralization of the test (outside the laboratory) while remaining linked to the health data systems of the competent authorities.
The positive validation from the France’s Haute Autorité de Santé (HAS) on November 27, 2020, confirms the benefits of the test. This new milestone will help accelerate the commercial roll-out of the test in France and on international markets. EasyCov test is reimbursed by the French social security since January 5, 2021.